Prescrire IN ENGLISH - HOME

Register online | Log in | My Prescrire

Issue contents

About Prescrire

english.prescrire.org

Welcome to the Prescrire in English website

Reliable, rigorously independent information on treatments and healthcare strategies,
to enable fully informed decision-making. Prescrire is financed by its subscribers.
No grants, no advertising. No shareholders, no sponsors.

Prescrire's other websites

Prescrire.org Les Formations - APP Prescrire Campus Éviter l'Évitable

In Prescrire's Spotlight

Bleeding with dabigatran, rivaroxaban, apixaban: no antidote, and little clinical experience

FEATURED REVIEW Dabigatran, rivaroxaban and apixaban are oral anticoagulants used to prevent or treat thrombosis. Difficulties in the management of bleeding weigh heavily in the balance of potential harm versus potential benefit of these drugs.
Full review (5 pages) available for download by subscribers.

1 June 2013

In the June issue of Prescrire International - Strontium ranelate (Protelos°) for osteoporosis in men: more dangerous than beneficial

FREE DOWNLOAD Strontium ranelate is used to treat postmenopausal osteoporosis in women. Serious and even life-threatening adverse effects have been reported since market release in 2005. The drug is now also licensed for the treatment of osteoporosis in men.
Full text available for free download.

1 June 2013

Prescrire: financial independence and transparent finances

Prescrire publishes its accounts each year.

1 June 2013

Personalised medicine based on pharmacogenetics: a critical approach is called for

As of early 2013, real therapeutic advances in the field of pharmacogenetics are still few and generally modest.

1 June 2013

Colorectal cancer: "antioxidants" have no preventive effect

"Antioxidants" have no place in the prevention of colorectal cancers. Furthermore, they may be harmful.

1 June 2013

Guard against drug companies' influence on healthcare professionals, starting with medical students

Teachers and students in the healthcare field have a key role to play in keeping pharmaceutical companies at arm's length, so as not to jeopardise the quality of their training and their practice.

1 June 2013

Washington conference produces a "Call to action on selling sickness"

Prescrire has endorsed the "Call to action on selling sickness", a statement that came out of the conference "Selling Sickness, 2013: People before Profits" held in Washington DC in February 2013. The statement is reproduced here.

15 May 2013

Lessons learnt and to be learnt: PRAC and CHMP say no to dangerous drug

In a published response to Gary Taube's essay "The science of obesity: what do we really know about what makes us fat?" (BMJ online, 16 April 2013), Prescrire welcomes the European Medicines Agency's refusal to grant marketing authorisation to the fixed-dose combination of topiramate and phentermine.

26 April 2013

Subscribe online for easy access to our database of articles in English

Subscribe today and enjoy instant access to the full database of articles in English published in Prescrire International since 1992. Subscribing online is fast and easy.

1 August 2012

No grants,
no advertising

Medicines
in Europe